I stopped taking Latuda (lurasidone) 11 days ago and now have severe anxiety; what should I do?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Contact Your Prescriber Immediately

You need to contact the healthcare provider who prescribed your Latuda right away to discuss your severe anxiety symptoms after stopping the medication 11 days ago. This could represent antipsychotic withdrawal or discontinuation syndrome, and requires prompt medical evaluation and management.

Understanding What May Be Happening

Antipsychotic Discontinuation Effects

While the FDA label for Latuda 1 does not specifically detail withdrawal syndromes, abrupt discontinuation of antipsychotic medications can lead to various symptoms. Your severe anxiety occurring 11 days after stopping Latuda may represent:

  • Rebound psychiatric symptoms - Return or worsening of the underlying condition that Latuda was treating
  • Discontinuation syndrome - Direct effects from stopping the medication
  • Withdrawal dyskinesia - Though typically manifests as movement symptoms rather than anxiety 2

Why This Matters

The timing (11 days post-discontinuation) is significant. Latuda has an 18-hour half-life and reaches steady state in 5 days 3, meaning the medication is now essentially cleared from your system. This timing aligns with when discontinuation effects would be most apparent.

Immediate Actions Required

1. Contact Your Prescriber Today

  • Call the provider who prescribed Latuda
  • If unavailable, contact your primary care physician or psychiatrist
  • If symptoms are severe or include suicidal thoughts, go to the emergency department

2. Do Not Self-Medicate

  • Do not restart Latuda without medical guidance
  • Avoid alcohol or other substances
  • Do not take benzodiazepines or other sedatives without prescription, as these carry their own risks 4

3. Monitor for Additional Symptoms

Watch for and report:

  • Worsening anxiety or panic attacks
  • Suicidal thoughts or behaviors (particularly important given FDA warnings about antipsychotic discontinuation) 1
  • Sleep disturbances
  • Agitation or restlessness
  • Return of psychotic symptoms if Latuda was prescribed for schizophrenia
  • Return of depressive symptoms if prescribed for bipolar depression

What Your Provider May Recommend

Potential Management Strategies

Reinitiation of Treatment:

  • Your provider may recommend restarting Latuda at a lower dose and tapering more gradually
  • The FDA label emphasizes that chronic antipsychotic treatment should be prescribed carefully, but does not provide specific tapering protocols 1

Alternative Approaches:

  • Evidence-based psychotherapies (e.g., CBT) for anxiety management 4
  • Non-benzodiazepine medications for anxiety if appropriate
  • Addressing the underlying condition (schizophrenia or bipolar depression) with alternative treatments

Supportive Care:

  • Close monitoring during this transition period
  • Addressing any sleep disturbances
  • Ensuring adequate support systems

Important Context About Latuda and Anxiety

Research shows that Latuda actually reduces anxiety symptoms in patients with schizophrenia 5, 6 and bipolar depression 7, 8. This means:

  • Your severe anxiety may represent loss of the therapeutic benefit Latuda was providing
  • The anxiety could be a symptom of your underlying psychiatric condition re-emerging
  • This underscores the importance of not stopping psychiatric medications abruptly without medical supervision

Critical Safety Considerations

Suicidal Thoughts Warning

The FDA label specifically warns about increased risk of suicidal thoughts and behaviors, particularly in young adults, when antidepressant medications (including those used for bipolar depression) are discontinued 1. If you experience any suicidal thoughts, seek emergency care immediately.

Why Abrupt Discontinuation Is Problematic

While the Latuda label doesn't provide specific tapering guidance, general principles from antipsychotic management 2, 9 indicate that:

  • Medications should be discontinued gradually when possible
  • Abrupt cessation can lead to symptom rebound
  • Close monitoring is essential during any medication changes

Moving Forward

The key message: This is a medical situation requiring professional evaluation. Your severe anxiety 11 days after stopping Latuda is not something to manage alone. The medication was prescribed for a reason (either schizophrenia or bipolar depression), and stopping it has created a clinical situation that needs expert assessment and management.

Do not delay in contacting your healthcare provider. If you cannot reach them within 24 hours, consider urgent care or emergency services, especially if symptoms worsen or you develop suicidal thoughts.

References

3
Research

Lurasidone: an antipsychotic with antidepressant effects in bipolar depression?

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2016

Related Questions

Is it normal to still have anxiety 12 days after stopping Latuda (lurasidone)?
I am 7 days off lurasidone (Latuda) and still experiencing anxiety; how long will it take for the anxiety to improve?
After being off lurasidone (Latuda) for two weeks and one day, when can I expect my anxiety to improve?
For a patient with severe anxiety on lurasidone (Latuda) 20 mg, what are the benefits of increasing the dose to 40 mg versus adding an anxiolytic?
What is the recommended approach to manage anxiety with lurasidone (Latuda), including appropriate dosing, monitoring, and adjunctive therapy?
How should I manage a 9‑month‑old female infant with a fever of 103 °F?
What is the most appropriate abortive therapy for a 68-year-old female patient with anxiety?
For a 15-year-old female with moderate depressive symptoms (PHQ-9A score 14), moderate anxiety symptoms (GAD-7 score 10), functional impairment, and passive suicidal ideation without a plan, what is the recommended first-line selective serotonin reuptake inhibitor (including FDA-approved age indication, starting dose, titration schedule, adequate trial duration, and monitoring), and what alternative should be used if the first SSRI is ineffective or not tolerated, according to American Academy of Pediatrics (AAP), American Academy of Child and Adolescent Psychiatry (AACAP), and FDA labeling?
What should be recorded as the immediate cause of death and how should the death certificate be completed for a patient who died from a stroke without a cranial CT scan?
Can Trichomonas vaginalis infection remain dormant for four years?
Will atomoxetine (Strattera) improve sensory reactivity, emotional lability, and anxiety in a patient with ADHD?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.